114 related articles for article (PubMed ID: 8973588)
1. In vivo cisplatin resistance of rat ascites hepatoma AH66.
Minamino T; Nomura M; Tamai M; Moritani S; Ohshima T; Miyamoto K
Cancer Lett; 1996 Nov; 108(2):153-6. PubMed ID: 8973588
[TBL] [Abstract][Full Text] [Related]
2. Involvement of multidrug resistance-associated protein 2 in in vivo cisplatin resistance of rat hepatoma AH66 cells.
Itoh Y; Tamai M; Yokogawa K; Nomura M; Moritani S; Suzuki H; Sugiyama Y; Miyamoto K
Anticancer Res; 2002; 22(3):1649-53. PubMed ID: 12168849
[TBL] [Abstract][Full Text] [Related]
3. In vivo cisplatin resistance depending upon canalicular multispecific organic anion transporter (cMOAT).
Minamino T; Tamai M; Itoh Y; Tatsumi Y; Nomura M; Yokogawa K; Suzuki H; Sugiyama Y; Ohshima T; Miyamoto K
Jpn J Cancer Res; 1999 Oct; 90(10):1171-8. PubMed ID: 10595747
[TBL] [Abstract][Full Text] [Related]
4. Characterization of naturally acquired multiple-drug resistance of Yoshida rat ascites hepatoma AH66 cell line.
Miyamoto K; Wakabayashi D; Minamino T; Nomura M; Wakusawa S; Nakamura S
Anticancer Res; 1996; 16(3A):1235-40. PubMed ID: 8702243
[TBL] [Abstract][Full Text] [Related]
5. Conjugated bilirubin induces multidrug resistance-associated protein 2 mRNA expression and in vivo cisplatin resistance in rat hepatoma AH66 cells.
Tamai M; Ito Y; Mirura H; Tsukada H; Yokogawa K; Nomura M; Moritani S; Miyamoto K
Anticancer Res; 2003; 23(6C):4781-7. PubMed ID: 14981926
[TBL] [Abstract][Full Text] [Related]
6. Sensitivity to antitumor drugs and vinblastine binding to membrane in rat ascites hepatoma AH66 cells.
Wakusawa S; Nakamura S; Inoko K; Miyamoto K
Chem Pharm Bull (Tokyo); 1992 Aug; 40(8):2182-4. PubMed ID: 1423778
[TBL] [Abstract][Full Text] [Related]
7. Multidrug resistance in Yoshida rat ascites hepatoma cell lines.
Miyamoto K; Wakusawa S; Nakamura S; Tajima K; Hidaka H
Anticancer Res; 1992; 12(3):649-53. PubMed ID: 1622121
[TBL] [Abstract][Full Text] [Related]
8. Highly malignant rat hepatoma AH66F cells respond to ascitic fluid.
Nomura M; Sugiura N; Yamamoto H; Miyamoto K
Anticancer Res; 1997; 17(1A):209-14. PubMed ID: 9066653
[TBL] [Abstract][Full Text] [Related]
9. Glutathione-S-transferase P-form dependent chlorambucil resistance in Yoshida rat ascites hepatoma cell lines.
Miyamoto K; Wakabayashi D; Minamino T; Nomura M
Cancer Lett; 1994 Apr; 78(1-3):77-83. PubMed ID: 7910111
[TBL] [Abstract][Full Text] [Related]
10. Forskolin inhibits the Gs-stimulated adenylate cyclase in rat ascites hepatoma AH66F cells.
Miyamoto K; Sanae F; Koshiura R; Matsunaga T; Hasegawa T; Takagi K; Satake T
Exp Cell Res; 1989 Sep; 184(1):219-27. PubMed ID: 2551705
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of P-glycoprotein-dependent multidrug resistance by an isoquinolinesulfonamide compound H-87 in rat ascites hepatoma AH66 cells.
Nakamura S; Minamino T; Nomura M; Wakusawa S; Miyamoto K; Hidaka H
Biol Pharm Bull; 1996 Jun; 19(6):886-9. PubMed ID: 8799494
[TBL] [Abstract][Full Text] [Related]
12. Comparative studies on the combined cytotoxic effect of forskolin with mitomycin C and responsiveness to forskolin in rat ascites hepatoma AH66 cells and AH66F cells.
Miyamoto K; Matsunaga T; Koshiura R; Takagi K; Satake T; Hasegawa T
J Pharmacobiodyn; 1987 Jul; 10(7):346-52. PubMed ID: 2826750
[TBL] [Abstract][Full Text] [Related]
13. Increase of sensitivity and uptake of vinblastine by reserpine in rat ascites hepatoma.
Wakusawa S; Miyamoto K; Koshiura R
Jpn J Pharmacol; 1984 Oct; 36(2):187-95. PubMed ID: 6513200
[TBL] [Abstract][Full Text] [Related]
14. Increase of vinblastine accumulation by inhibitors of calmodulin-dependent cell functions in rat ascites hepatoma AH66 cells.
Wakusawa S; Takeda K; Miyamoto K; Hidaka H
Anticancer Res; 1992; 12(6B):2021-4. PubMed ID: 1363514
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of natural resistance to vincristine in rat ascites hepatoma AH66.
Inaba M; Takayama K; Sakurai Y
Gan; 1981 Aug; 72(4):562-8. PubMed ID: 7308668
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the metastatic ability of rat hepatoma cells in chick embryos by the polymerase-chain reaction.
Yamamoto H; Endo Y; Nomura M; Miyamoto K; Sasaki T
Anticancer Res; 1996; 16(1):413-7. PubMed ID: 8615646
[TBL] [Abstract][Full Text] [Related]
17. Reverse relationship between malignancy and cyclic AMP-dependent protein kinase activity in Yoshida rat ascites hepatomas.
Miyamoto K; Nakamura S; Nomura M; Yamamoto H; Sanae F; Hidaka H
Cancer Lett; 1993 Aug; 72(3):179-82. PubMed ID: 8402589
[TBL] [Abstract][Full Text] [Related]
18. Effects of 5'-DFUR and lentinan on cytokines and PyNPase against AH66 ascites hepatoma in rats.
Ogawa T; Ohwada S; Sato Y; Izumi M; Nakamura S; Takeyoshi I; Kawashima Y; Ohya T; Koyama T; Morishita Y
Anticancer Res; 1999; 19(1A):375-9. PubMed ID: 10226570
[TBL] [Abstract][Full Text] [Related]
19. Resistance to cisplatin-induced apoptosis via PI3K-dependent survivin expression in a rat hepatoma cell line.
Asechi H; Hatano E; Nitta T; Tada M; Iwaisako K; Tamaki N; Nagata H; Narita M; Yanagida A; Ikai I; Uemoto S
Int J Oncol; 2010 Jul; 37(1):89-96. PubMed ID: 20514400
[TBL] [Abstract][Full Text] [Related]
20. The inhibitory effects of horse anti-rat AFP antiserum on the uptake of 2-deoxy-D-glucose by AFP-producing rat hepatoma cells.
Ohkawa K; Tsukada Y; Hibi N; Hirai H
Int J Cancer; 1984 Apr; 33(4):497-502. PubMed ID: 6200448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
